Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Jan-22 | Jan-23 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 828 | 1,063 | 950 | 944 | 957 | 911 | 1,249 | 588 | 1,667 | 878 | | 777 |
% Growth | NA | 28.4% | -10.6% | -0.6% | 1.3% | -4.8% | 37.1% | -52.9% | 183.6% | -47.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | (693) | (896) | (806) | (817) | (834) | (811) | (1,132) | (680) | (1,561) | (922) | | (879) |
Gross Profit | 135 | 167 | 144 | 127 | 122 | 99 | 116 | (92) | 106 | (44) | | (101) |
% Revenue | 16.3% | 15.7% | 15.1% | 13.4% | 12.8% | 10.9% | 9.3% | -15.7% | 6.4% | -5.0% | | -13.0% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (5) | (7) | (7) | (14) | (14) | (16) | (13) | (17) | (16) | (12) | | (10) |
General and Admin | (46) | (60) | (51) | (53) | (68) | (94) | (77) | (84) | (226) | (117) | | (100) |
Other Inc / (Exp) | (24) | (31) | (9) | (1) | (3) | (7) | (9) | (9) | (25) | (27) | | (26) |
Total Operating Exp | (76) | (98) | (67) | (68) | (86) | (117) | (99) | (110) | (267) | (156) | | (135) |
| | | | | | | | | | | | |
Operating Income | 60 | 69 | 77 | 59 | 36 | (18) | 17 | (202) | (161) | (199) | | (237) |
% Revenue | 7.2% | 6.5% | 8.1% | 6.3% | 3.8% | -1.9% | 1.4% | -34.4% | -9.6% | -22.7% | | -30.5% |
| | | | | | | | | | | | |
Interest Expense | (5) | (8) | (8) | (2) | (2) | (6) | 6 | (11) | (18) | (3) | | (7) |
Pre-tax Income | 54 | 60 | 69 | 57 | 35 | (23) | 23 | (213) | (178) | (202) | | (244) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (14) | (14) | (17) | (15) | (8) | 5 | (7) | 52 | 39 | 14 | | 5 |
Net Income to Company | 41 | 47 | 52 | 42 | 27 | (18) | 15 | (161) | (139) | (188) | | (239) |
% Margin | 4.9% | 4.4% | 5.5% | 4.5% | 2.8% | -2.0% | 1.2% | -27.4% | -8.3% | -21.4% | | -30.7% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (4) | 15 | | 23 |
Net Income to Stockholders | 41 | 47 | 52 | 42 | 27 | (18) | 15 | (161) | (143) | (174) | | (216) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 41 | 47 | 52 | 42 | 27 | (18) | 15 | (161) | (143) | (174) | | (216) |
% Margin | 4.9% | 4.4% | 5.5% | 4.5% | 2.8% | -2.0% | 1.2% | -27.4% | -8.6% | -19.8% | | -27.8% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.45 | 0.51 | 0.58 | 0.37 | 0.22 | (0.15) | 0.12 | (1.19) | (1.03) | (1.28) | | (1.60) |
Diluted EPS (Continuing Ops) | 0.45 | 0.51 | 0.58 | 0.37 | 0.22 | (0.15) | 0.12 | (1.19) | (1.03) | (1.28) | | (1.60) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 90.39 | 91.79 | 90.64 | 114.75 | 120.56 | 118.89 | 128.39 | 135.42 | 138.45 | 135.56 | | 135.54 |
WA Diluted Shares Out. | 90.39 | 91.79 | 90.64 | 114.75 | 120.56 | 118.89 | 128.39 | 135.42 | 138.45 | 135.56 | | 135.54 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 54 | 60 | 69 | 57 | 35 | (23) | 23 | (213) | (178) | (202) | | (244) |
Addback: Net Interest Expense | 5 | 8 | 8 | 2 | 2 | 6 | (6) | 11 | 18 | 3 | | 7 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 2 | 3 | 6 | 13 | 23 | 3 | | 8 |
Addback: Depreciation & Amortization | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9 | | 9 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | | 11 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | (0) | 0 | 0 | (0) | (0) | (0) | 0 | | (1) |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | | 7 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (3) | (2) | (0) | (2) | 0 | 1 | 0 | (8) | (1) | (2) | | (2) |
Adjusted EBITDA | 58 | 67 | 78 | 59 | 41 | (9) | 29 | (189) | (130) | (166) | | (204) |
% Margin | 7.0% | 6.3% | 8.2% | 6.2% | 4.2% | -1.0% | 2.3% | -32.2% | -7.8% | -18.9% | | -26.3% |
| | | | | | | | | | | | |
Adjusted EBIT | 57 | 66 | 77 | 57 | 38 | (13) | 23 | (195) | (139) | (175) | | (213) |
% Margin | 6.9% | 6.3% | 8.1% | 6.0% | 4.0% | -1.4% | 1.9% | -33.1% | -8.3% | -19.9% | | -27.4% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 41 | 47 | 52 | 42 | 27 | (18) | 15 | (161) | (139) | (188) | | (239) |
Addback: Unusual Items | (3) | (2) | (0) | (2) | 0 | 2 | 0 | (5) | (1) | 22 | | 15 |
Less: Tax Benefit of Unusual Items (26%) | 1 | 1 | 0 | 1 | (0) | (0) | (0) | 1 | 0 | (6) | | (4) |
Adjusted Net Income | 39 | 45 | 52 | 41 | 27 | (16) | 16 | (165) | (140) | (172) | | (227) |
% Margin | 4.7% | 4.2% | 5.5% | 4.3% | 2.8% | -1.8% | 1.3% | -28.1% | -8.4% | -19.6% | | -29.3% |